Skip to main content
. Author manuscript; available in PMC: 2018 Nov 15.
Published in final edited form as: Eur J Pharm Sci. 2017 Aug 1;109:78–85. doi: 10.1016/j.ejps.2017.07.031

TABLE 2.

Demographic and baseline characteristics of the subjects enrolled in Experiment 2 of the clinical study.

Placebo
0-mg
(n=8)		 GET 73
100-mg
(n=6)		 GET 73
300-mg
(n=6)		 GET 73
450-mg
(n=6)		 GET 73
450-mg twice/day
(n=6)
Age (years) 34.5(10.7) 38.2(13.9) 47.5(16.1) 42.7(9.6) 44.2(9.0)
Weight (kg) 79.6 (8.91) 78.1(8.65) 75.4(5.88) 80.2(5.27) 83.8(11.78)
Height (cm) 182.8(8.3) 172.2(1.8) 173.8(3.9) 175.2(5.3) 178.7(6.2)
BMI (kg/m2) 23.9(2.60) 26.3(2.68) 25.0(2.34) 26.2(2.09) 26.1(1.92)

Results are reported as M and (SD); BMI: Body Mass Index